4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-003287
Options or other derivatives
- President and CEO acquired 315,316 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Blume-Jensen Peter · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +225,226 | 225,226 | D |
| 2024-03-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +90,090 | 90,090 | I |
Loading xslF345X05/form4.xml…